Show more

Like most websites we uses cookies. In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. These cookies are completely safe and secure and will never contain any sensitive information. They used only by us.

The 2020 CIPA Life Sciences Webinar Series

Tuesday 17th November 2020


Topic: Hot Topics in Life Sciences IP and SPCs Case law update

Date: Tuesday 17th November, 2020

Time: 12:00 - 1:15pm GMT

Agenda to Include:

Panel discussion on the issues of focus for small and large companies in the life sciences industry.

  • Brexit

  • Covid implications

Case law update on SPCs

Speakers:

Susan Chiappinelli, GlaxoSmithKline

Susan Chiappinelli started at GSK as a patent trainee in 1998.  Since then she has managed IP in a range of areas including large and small molecule and cell and gene therapies, vaccines and general tech such as gene editing and AI.  She is usually based in Stevenage at GSK’s UK R&D hub, leading a team of UK and US patent attorneys who provide IP support to all stages of the GSK pharma pipeline from early target validation through to patent expiry and beyond. 

 Sally Curran, AstraZeneca

Sally is a member of the AstraZeneca IP Leadership Team and leads a team supporting their Respiratory & Immunology (R&I) therapy area.  Her experience at AstraZeneca covers IP strategy across the entire spectrum of research, development and commercialisation.  In addition to leading a team handling global patent procurement Sally manages IP portfolios for major on-market products and has also been involved in significant in-licences and acquisitions in the R&I therapy area.  Sally was also instrumental in defining AstraZeneca’s IP strategy for open innovation activities via its Open Innovation portal (www.openinnovation.astrazeneca.com).  She is heavily involved in people development activities across AstraZeneca’s Legal department as a whole, and is active in Inclusion & Diversity and mentoring initiatives within the company and in the broader Cambridge area.  Prior to joining AstraZeneca in 2010 Sally spent more than a decade in private practice IP firms.

Rob Stephen, CMS

Gareth Morgan, CMS

Moderator:

Marion Rees, Adiga Life Sciences 

Marion is a Chartered Patent Attorney and European Patent Attorney with 20 years’ experience working in-house for small and large life science companies including GSK, Oxford Nanopore Technologies and Circassia. She is a member of the CIPA Life Sciences Committee and has for several years been part of the organising committee for the annual CIPA Life Sciences conference. She is currently VP of Intellectual Property and Legal Affairs at Adiga Life Sciences in Oxford.

 

 

Previous Day                              Next Day

 

 

Event managed by:

© 2016 Sequence of Events Ltd.
Registration No. 08672344
Registered Address: 71 Knowl Piece, Wilbury Way, Hertfordshire, SG4 0TY
Registered in England & Wales

Powered by BookingLive: Online Booking System